[ad_1]
The first treatment of stem cell disease, Parkinson's disease, will be tested for the world's first in Japan. The clinical trial will begin on August 1st.
Parkinson's disease is a degenerative disease that results from the slow, progressive destruction of dopamine-synthesizing neurons. Because the affected area plays an important role in movement control, patients exhibit rigid, jerky and uncontrollable movements, tremors and postural instability.
Research of a team from Kyoto University in Japan provides for the injection of Parkinson's in the brain. Five million pluripotent stem cells capable of transforming into any cell type, DC News writes.
All this comes as a result of a test on monkeys injected with human stem cells that helped them improve the movements without the appearance of tumors.
Stem cells from healthy donors will develop into neurons that produce dopamine, a neurotransmitter that interferes with motor control. This study included 7 patients aged 50-69 years, but the number of patients reached 10 million worldwide
Lit:
Hypotension reduces the risk of dementia [19659003] Too calcium in the blood is dangerous to health
Photo Source: shutterstock.com
[ad_2]
Source link
